Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 19 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

40%

6 of 15 completed trials have results

Key Signals

1 recruiting6 with results

Enrollment Performance

Analytics

Phase 2
9(75.0%)
N/A
1(8.3%)
Phase 3
1(8.3%)
Phase 1
1(8.3%)
12Total
Phase 2(9)
N/A(1)
Phase 3(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT04401475Phase 2Suspended

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC Vs. Placebo + SOC in Adult Hospitalized Patients with COVID-19

Role: collaborator

NCT03680131Phase 2Completed

Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis

Role: collaborator

NCT05799651Phase 1Active Not Recruiting

Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults

Role: collaborator

NCT04467905Phase 2Completed

ReVeRA-201: Etripamil in Atrial Fibrillation, Phase 2

Role: collaborator

NCT06036186Not ApplicableCompleted

Study for the Treatment of Heart Failure With Preserved Ejection Fraction Associated With High Blood Pressure Using Right Atrial Pacing Controlled by the PressurePaceTM System

Role: collaborator

NCT05706454Phase 2Recruiting

Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia

Role: collaborator

NCT05153798Unknown

Evaluation of PerioMonitor for Detection of Oral Inflammatory Load (OIL) in Human Subjects

Role: collaborator

NCT01387802Completed

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Role: collaborator

NCT01559038Completed

Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis

Role: collaborator

NCT01387815Completed

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis

Role: collaborator

NCT01926444Phase 2Completed

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

Role: collaborator

NCT01386684Completed

Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study

Role: collaborator

NCT00550732Phase 2Completed

A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2)

Role: collaborator

NCT02050594Completed

Ipilimumab 12-month Intensive Pharmacovigilance Protocol

Role: collaborator

NCT01455844Phase 2Completed

TRIal For Efficacy of Capre on hyperTriglyceridemiA

Role: collaborator

NCT00328263Phase 3Completed

Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adult Patients

Role: collaborator

NCT01516151Phase 2Completed

Assess the Safety and Efficacy of NKPL66 (CaPre™) in the Treatment of Mild-to-high Hypertriglyceridemia

Role: collaborator

NCT01078597Completed

A Study on the Prevalence of the Modified Citrullinated Vimentin Anti-body (Anti-MCV) in an Irish Rheumatoid Arthritis (RA) Population and to Assess the Impact of Anti-MCV and the Anti-cyclic-citrullinated Peptide Antibody (Anti-CCP) Status on the Management of Irish Patients With Early RA

Role: collaborator

NCT00454831Phase 2Completed

Efficacy and Safety of HEP-40 Chitosan for Mild to Moderately Elevated Cholesterol

Role: collaborator

All 19 trials loaded